ArticleBalkan journal of medical genetics : BJMG2025
Shared Inflammatory Gene Programs between Immune Thrombocytopenia and CKD-Related Autoimmune Nephropathies: An Exploratory Transcriptomic and Bioinformatic Study.
Article in Balkan journal of medical genetics : BJMG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To define peripheral transcriptomic alterations in newly diagnosed immune thrombocytopenia (ITP) and explore shared disease-associated gene programs with chronic kidney disease (CKD) related autoimmune nephropathies (membranous nephropathy, MN; IgA nephropathy, IgAN). Methods: CD19+ B cells from newly diagnosed ITP patients and healthy controls (n = 4/group) underwent high-throughput sequencing. To complement the limited cohort, six publicly available ITP-related GEO datasets were additionally collected as supplementary transcriptomic resources. Differential expression analyses were performed separately in the dataset and the public datasets using dataset-appropriate workflows, and the intersecting differentially expressed genes were retained as common DEGs for downstream analyses. Functional enrichment was assessed using GSEA, and candidate genes were prioritized using machine-learning approaches, including LASSO, SVM-RFE, and Random Forest, followed by protein-protein interaction (PPI) network analysis. TNF, NLRP3, and IL1B were further validated by qPCR in newly diagnosed ITP patients, remission ITP patients, and healthy controls. CKD, MN and IgAN associated gene sets were curated from GeneCards and OMIM for overlap and PPI analyses. Results: Intersecting the differential expression results from the and public datasets yielded 498 common DEGs, including 243 upregulated and 255 downregulated genes. These genes were enriched in inflammatory and immunometabolic pathways. Machine learning analyses converged on SRGN as a prioritized candidate gene. PPI analysis highlighted inflammatory and immune-related nodes, including TNF and IL1B, while qPCR confirmed increased expression of TNF, NLRP3, and IL1B in newly diagnosed ITP patients, with reduced NLRP3 and IL1B expression in remission. Overlap analyses identified 39 genes shared with CKD, 24 with MN, and 37 with IgAN, with TNF emerging as a recurrent high-connectivity inflammatory node across the overlap derived PPI networks. Conclusions: Newly diagnosed ITP is associated with a distinct inflammatory and immunometabolic B-cell transcriptional program. The recurrent identification of TNF centered and inflammasome-linked signals suggests shared disease associated inflammatory components between ITP and CKD related autoimmune nephropathies. These molecular signatures may contribute to future biomarker development, renal risk stratification, or translational targeting across hematologic and renal autoimmunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.